Transaction · 0001628280-26-060234

Gold Kelly

Gold Kelly, CFO, reported an open-market or private purchase at Camp4 Therapeutics Corp involving 10000.000000 shares for an estimated $39600.00. Reported holdings after the transaction were 10000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCFO
CAMPCamp4 Therapeutics Corp
Filing timeSep 02
Trade dateAug 31, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.80
Pre-filing
1mo ago -9.2%1w ago +13.7%1d ago +9.2%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

CAMP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CAMP since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001628280-26-060234
Common Stock
Transaction date
Aug 31, 2026
Filed Sep 02, 2026, 11:50 PM · 2d delay
Shares
10.0k sh
$396 per share
Estimated value
$3.96M
Computed from shares × price
Holdings after
10.0k sh
Indirect · By Spouse

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
CFO Buy Large Holdings Increase
+34score
Filing-only score

+34

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares reported herein were purchased in the open market in multiple transactions at prices ranging from $3.88 to $4.00, inclusive. The price reported in Column 4 is a weighted average price. The…

  2. F2

    The shares reported herein are held in a brokerage account in the name of David Gold, the Reporting Person's spouse. The Reporting Person does not exercise investment control over this account. The Re…

  3. F3

    Includes 2,039 shares previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 1…

Original filing · 0001628280-26-060234
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CAMP